Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1458098

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1458098

Global Metabolomics Market Size, Share, Growth Analysis, By Product and service(Metabolomics Instruments, Separation Tools), By End-use(Academic and Research Institutes, Pharmaceutical & Biotechnology Companies) - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Metabolomics Market size was valued at USD 2.83 Billion in 2022 and is poised to grow from USD 3.20 Billion in 2023 to USD 8.51 Billion by 2031, at a CAGR of 13 % during the forecast period (2024-2031).

The increased prevalence of chronic diseases, the growing need for personalized medication, and technological improvements have all contributed to the steady growth of the worldwide metabolomics market. The goal of the metabolomics market is to give scientists and medical professionals resources and instruments that will enable them to comprehend the fundamental biochemical processes that underlie biological systems. Scientists can learn more about the underlying causes of disease and find possible targets for future treatments by examining the metabolites that cells create. The creation of biomarkers for illness diagnosis and tailored medicine are further uses for metabolomics. Metabolomics analysis is now more faster and more accurate thanks to the development of high-throughput platforms for metabolite profiling, such as nuclear magnetic resonance spectroscopy and mass spectrometry. Because of the volume and complexity of the data generated, metabolomics data interpretation can be difficult. The rising incidence of chronic diseases, the growing need for tailored medication, and technological improvements are driving the worldwide metabolomics market. The market faces difficulties such the high price of instruments, the absence of standards, and the scarcity of qualified workers. There are plenty of prospects in the market for government, business, and academic cooperation as well as for the creation of new applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Metabolomics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Metabolomics Market Segmental Analysis

The product, application, and geographic segments of the worldwide metabolomics market are divided up. The market is divided into three segments based on the kind of product and service: metabolomics instruments, separation tools, and detection tools. The market is divided into academic and research institutions, pharmaceutical and biotechnology firms, contract research organizations, and others based on the end-use segmentation. The market is divided into five regions: Latin America, Middle East and Africa, Asia Pacific, Europe, and North America.

Drivers of the Global Metabolomics Market

The market has been significantly influenced by the ongoing developments in metabolomics technology, including mass spectrometry, NMR spectroscopy, and data analysis tools. These developments improve metabolomics analysis's sensitivity, accuracy, and throughput, allowing scientists to draw deeper conclusions from metabolomics data.

Restraints in the Global Metabolomics Market

One major obstacle to the market is the high cost of metabolomics devices, consumables, and data analysis tools. The use of metabolomics technology is restricted, especially in environments with limited resources, by the initial cost of setting up metabolomics laboratories and the continuing costs for consumables and maintenance.

Market Trends of the Global Metabolomics Market

Integrating metabolomics data with genomes, proteomics, and transcriptomics data is known as the integration of multi-omics techniques. This integration offers insights into intricate biological processes and the causes of disease, enabling a thorough understanding of biological systems. Systems biology and customized medicine are projected to advance as a result of the integration of multi-omics data.

Application of Metabolomics in Microbiome Research: The study of the metabolic interactions between host organisms and the microbial communities they are linked with is made possible by the growing application of metabolics in microbiome research. Understanding the metabolites generated by the microbiome and how they affect host health and illness is possible through metabolomics. It is anticipated that the use of metabolomics in microbiome research will spur additional advancements in the fields of microbial ecology, tailored nutrition, and gut health.

Product Code: SQMIG35H2164

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Metabolomics Market by Product and service

  • Market Overview
  • Metabolomics Instruments
  • Separation Tools
  • and Detection Tools

Global Metabolomics Market by End-use

  • Market Overview
  • Academic and Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • and other End Users

Global Metabolomics Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Agilent Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Waters Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Metabolon, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Human Metabolome Technologies, Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agios Pharmaceuticals, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LECO Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biocrates Life Sciences AG (Austria)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimazu Europe GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molecular Devices, LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Phenomenex, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cambridge Isotope Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sciex (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • JEOL Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!